ArticleHIV medicine2025
A programmatic assessment of dolutegravir adverse events and discontinuations in Uganda.
Eva Agnes Laker Odongpiny et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
6 papers cite it
this papercites it
ArticleHIV medicine2025
Eva Agnes Laker Odongpiny et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.